(2-Methylbenzo[d]oxazol-5-yl)methanamine hydrochloride

Catalog No.: 
ACUKWV090
CAS No.: 
903556-82-1
Molecular Formula: 
C9H11ClN2O
Molecular Weight: 
198.65
(2-Methylbenzo[d]oxazol-5-yl)methanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$187.00InquiryInquiry
250mg95%$372.00InquiryInquiry
1g95%$1145.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-Methylbenzo[d]oxazol-5-yl)methanamine hydrochloride
IUPAC Name(2-Methylbenzo[d]oxazol-5-yl)methanamine hydrochloride
MDL No.MFCD18089190
Molecular FormulaC9H11ClN2O
Molecular Weight198.65
SMILESNCC1=CC=C(OC(C)=N2)C2=C1.[H]Cl
InChI KeyFMCIDNVYQOQGEB-UHFFFAOYSA-N
Synonym(2-Methylbenzo[d]oxazol-5-yl)MethanaMine hydrochloride;(2-Methyl-1,3-benzoxazol-5-yl)-methylamine hydrochloride;C-(2-Methyl-benzooxazol-5-yl)-methylamine hydrochloride;(2-Methyl-benzooxazol-5-yl)-methylamine hydrochloride
CAS No.903556-82-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACUKWV090 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACUKWV090 route product structure diagram
    ACUKWV090903556-82-1
Inquiry

2. ACUKWV090 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUKWV090 route product structure diagram
    ACUKWV090903556-82-1
Inquiry

3. ACUKWV090 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUKWV090 route product structure diagram
    ACUKWV090903556-82-1
Inquiry

Comments (0)